Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Multicenter Prospective Phase II Study of Rituximab Combined, Bortezomib, Lenalidomide, Dexamethasone Followed By Lenalidomide Maintenance (R-VRD) in Patients with Waldenstrom's Macroglobulinemia (KMM1803)

Ho Sup Lee, Dajung Kim, Sung-Hoon Jung, Je-Jung Lee, Kihyun Kim, Chang-Ki Min, Jae Hoon Lee, Won-Sik Lee, JiHyun Lee, Gyeong Won Lee, Min Kyoung Kim, Ho-Jin Shin, Hyo Jung Kim, Jun Ho Yi

Blood (2023) 142 (Supplement 1): 2037.

https://doi.org/10.1182/blood-2023-180325

Published: 2023

Journal Articles

Genetic Variations in Multiple Myeloma with Extramedullary Disease

Dajung Kim, Seri Jeong, Kevin Song, Jae-Cheol Jo, JiHyun Lee, Jee-Yeong Jeong, Ho Sup Lee

Blood (2023) 142 (Supplement 1): 4742.

https://doi.org/10.1182/blood-2023-181468

Published: 2023

Journal Articles

A Novel Small Animal Model to Test on-Target Off-Tumor Cytoxicity of Adoptive Immune Therapies

Mauro Castellarin, PhD, Joseph A. Fraietta, PhD, Jihyun Lee, PhD, John Scholler, Yangbing Zhao, PhD MD, Carl H. June, MD

Blood (2015) 126 (23): 5432.

https://doi.org/10.1182/blood.V126.23.5432.5432

Published: 2015

Journal Articles

ICOS-based chimeric antigen receptors program bipolar T H 17/T H 1 cells

Sonia Guedan, Xi Chen, Aviv Madar, Carmine Carpenito, Shannon E. McGettigan, Matthew J. Frigault, Jihyun Lee, Avery D. Posey, Jr, John Scholler, Nathalie Scholler, Richard Bonneau, Carl H. June

Blood (2014) 124 (7): 1070–1080.

https://doi.org/10.1182/blood-2013-10-535245

Published: 2014

Includes: Supplemental data

Journal Articles

Distinct Signaling By Chimeric Antigen Receptors (CARs) Containing CD28 Signaling Domain Versus 4-1BB In Primary Human T Cells

Omkar Uday Kawalekar, MS, BS, Avery D. Posey, Jr., Joseph Fraietta, Jihyun Lee, John Scholler, Yangbing Zhao, Carl H. June, MD

Blood (2013) 122 (21): 2902.

https://doi.org/10.1182/blood.V122.21.2902.2902

Published: 2013

NARROW

Multicenter Prospective Phase II Study of Rituximab Combined, Bortezomib, Lenalidomide, Dexamethasone Followed By Lenalidomide Maintenance (R-VRD) in Patients with Waldenstrom's Macroglobulinemia (KMM1803)

Genetic Variations in Multiple Myeloma with Extramedullary Disease

A Novel Small Animal Model to Test on-Target Off-Tumor Cytoxicity of Adoptive Immune Therapies

ICOS-based chimeric antigen receptors program bipolar T H 17/T H 1 cells

Distinct Signaling By Chimeric Antigen Receptors (CARs) Containing CD28 Signaling Domain Versus 4-1BB In Primary Human T Cells

Email alerts

ASH Publications

American Society of Hematology

Multicenter Prospective Phase II Study of Rituximab Combined, Bortezomib, Lenalidomide, Dexamethasone Followed By Lenalidomide Maintenance (R-VRD) in Patients with Waldenstrom's Macroglobulinemia (KMM1803)

Genetic Variations in Multiple Myeloma with Extramedullary Disease

A Novel Small Animal Model to Test on-Target Off-Tumor Cytoxicity of Adoptive Immune Therapies

ICOS-based chimeric antigen receptors program bipolar T H 17/T H 1 cells

Distinct Signaling By Chimeric Antigen Receptors (CARs) Containing CD28 Signaling Domain Versus 4-1BB In Primary Human T Cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only